Twist Bioscience

The deals cover the company's synthetic DNA and next-generation sequencing products, including its newly launched target enrichment line.

The company, which recently entered the next-generation sequencing sample prep market, said it has raised $259 million since it was founded in 2013.

At the AGBT conference this week, the DNA synthesis discussed the new capture products and its overall business.

Companies in the life science tools and molecular diagnostics spaces provided updates on their businesses at the 36th annual JP Morgan Healthcare Conference this week in San Francisco.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.